Physician profile
Nathan M Melton
NPI 1083734438
$23,730.07
in general payments reported to CMS, 2019-2025
24 companies · $2,241 in 2025
The $2,241 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,871 · 2020: $1,620 · 2021: $1,530 · 2022: $5,097 · 2023: $2,965 · 2024: $3,406 · 2025: $2,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,111 · Travel and Lodging: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,111.15 |
| Travel and Lodging | $3,500.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,364.51 | 2019-2025 | |
| Cdc Medical LLC | $8,075.96 | 2019-2024 | |
| Stryker Corporation | $3,101.85 | 2019-2025 | Gamma, Pangea, Mako |
| Zimmer Biomet Holdings, INC. | $860.01 | 2019-2025 | Persona, G7, Arcos |
| Smith+Nephew, INC. | $826.10 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Evos |
| Depuy Synthes Sales INC. | $564.42 | 2021-2025 | Monovisc, Orthovisc, Lcp |
| Legacy Ortho LLC | $246.88 | 2024-2025 | |
| Horizon Therapeutics Plc | $246.02 | 2019-2021 | |
| Sanara Medtech INC. | $224.07 | 2021-2025 | Celleraterx |
| Medline Industries Lp | $222.91 | 2023-2024 | |
| Integra Lifesciences Corporation | $164.48 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medshape, INC. | $150.00 | 2025 | Dynanail |
| Kuros Biosciences USA, INC | $129.10 | 2024 | Magnetos |
| Heron Therapeutics, INC. | $124.22 | 2024 | Zynrelef |
| Conformis, INC. | $119.39 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $90.42 | 2024 | Biobrace 23mm |
| Paragon 28, INC. | $45.61 | 2021-2023 | Portfolio |
| Treace Medical Concepts, INC. | $35.62 | 2022 | |
| Globus Medical, INC. | $35.50 | 2022 | |
| Exactech, INC. | $31.71 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $29.20 | 2025 | Zilretta, Iovera, Exparel |
| Kairos Surgical INC | $15.73 | 2019 | |
| Orthofix Medical, INC. | $13.23 | 2022 | |
| Forte Bio-Pharma LLC | $13.13 | 2024 | Prolate, Nalocet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Melton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.